Ocugen-Bharat Biotech Partnered COVID-19 Booster Covaxin Neutralizes Omicron, Delta Variants
Ocugen Inc (NASDAQ: OCGN) and its partner, Bharat Biotech, announced results from a COVID-19 vaccine booster study conducted at Emory University.
20 Stocks Moving in Monday’s Pre-Market Session
Gainers
Bone Biologics Corporation (NASDAQ: BBLG) rose 32.1% to $4.53 in pre-market trading.
Ocugen Reveals Data From Bharat Biotech Partnered Covaxin Booster Dose
Ocugen Inc (NASDAQ: OCGN) announced that a booster shot of the COVID-19 vaccine candidate
Top 10 Most Searched Tickers On Benzinga Pro In 2021: Tesla, Apple, AMC, GameStop And More
Many of Benzinga’s most read stories in 2021 centered on the world of cryptocurrency, with Dogecoin (CRYPTO: DOGE) receiving huge interest from investors and readers.
Top 25 WallStreetBets Mentions for 2021
These are the 25 stocks most mentioned on wallstreetbets in 2021 (Symbol, Number of Mentions, Percentage each stock was mentioned out of total of all stocks mentioned in 2021):
SPY 33149 (9.27%)
TSLA 28903 (8.08%)
GME 19161 (5.36%)
NVDA 11410 (3.19%)
AAPL 8047 (2.25%)
AMD 8018 (2.24%)
AMC 7984 (2.23%)
LCID 5934 (1.66%)
Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity And Safety Data From COVAXIN (BBV152), COVID-19 Candidate Vaccine, In Children 2 – 18 YEARS
Ocugen, Inc. (NASDAQ:OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced today that its partner, Bharat Biotech, posted results from a
Watching Ocugen Shares; Times Of India Reports ‘Covaxin showed better antibody response in 2-18 year olds than adults: Bharat Biotech’
https://timesofindia.indiatimes.com/india/covaxin-showed-better-antibody-response-in-2-18-year-olds-than-adults-bharat-biotech/articleshow/88594422.cms
45 Biggest Movers From Yesterday
Gainers
Puxin Limited (NYSE: NEW) shares surged 80% to close at $0.54 on Wednesday after reporting results for the second quarter.
26 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Puxin Limited (NYSE: NEW) jumped 100.5% to $0.6016 after reporting results for the second quarter.